It seems to make sense to me since the FDA deficiency letter goes out before the 100 day meeting. I think it’s plausible that company could have known since then. Only one way to know for sure, and that’s to see the actual document pointing out the deficiencies.
AVH Price at posting:
$3.58 Sentiment: Sell Disclosure: Not Held
